Delek US Holdings, Inc. filings document the formal reporting record for a downstream energy company with refining, logistics, pipeline, and renewable-fuels assets. Form 8-K disclosures cover operating and financial results, quarterly dividends, material agreements, credit-facility amendments, capital-structure changes, and executive leadership matters.
Proxy and annual-meeting filings describe board elections, executive compensation votes, the 2026 Long-Term Incentive Plan, auditor ratification, and shareholder voting results. The filings also identify Delek US common stock on the New York Stock Exchange and record its relationship with Delek Logistics Partners, LP, including general partner and majority limited partner interests.
Delek US Holdings, Inc. (DK) has a notice of proposed sale of company stock under Rule 144 filed on behalf of director William J. Finnerty. The filing covers 1,457 shares of common stock held at Fidelity Brokerage Services LLC, with an indicated aggregate value of $94,267.90, and lists the NYSE as the trading market.
The shares to be sold trace to restricted stock vesting on June 10, 2025 from the issuer as compensation. The notice also reports that during the past three months, Finnerty sold 5,000 shares of Delek US Holdings common stock for total proceeds of $239,100.00. The form is signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for William Finnerty.
Delek US Holdings, Inc. (DK) reported that executive vice president, Special Projects, Reuven Spiegel filed a Form 4 for one open-market sale of 10,000 shares of common stock on August 18, 2026 at $68.21 per share. After this transaction, he directly holds 36,435 shares. The sale was made pursuant to a Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Delek US Holdings, Inc. (DK) reported that Mark Wayne Hobbs, EVP of Delek Logistics, sold a total of 20,000 shares of common stock on 2026-08-17 in open-market transactions under a Rule 10b5-1 trading plan. The sales occurred in two tranches at weighted average prices of $64.364 and $65.284 per share, with each price representing multiple trades within specified ranges. The filing notes that these transactions complete this 10b5-1 plan.
Delek US Holdings, Inc. (DK) reported that President & CEO Avigal Soreq sold a total of 80,000 shares of common stock on 2026-08-17 in four open‑market transactions under a Rule 10b5-1 trading plan. The weighted average sale prices were $64.383 for 4,603 shares, $65.351 for 4,623 shares, $66.616 for 57,700 shares, and $67.202 for 13,074 shares, with each price representing a weighted average over multiple trades within the disclosed intraday price ranges. A footnote states these trades were made pursuant to a 10b5‑1 plan intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) and that these transactions complete this plan.
Delek US Holdings, Inc. (DK) received a Rule 144 notice relating to proposed sales of its common stock by officer Reuven Spiegel. The notice covers the potential sale of up to 10,000 shares of DK common stock, held at Fidelity Brokerage Services LLC and listed on the NYSE. These shares were acquired as compensation through restricted stock vesting in two blocks of 5,629 and 4,371 shares, with vesting dates of June 10, 2025 and December 10, 2025. The filing also reports that Spiegel sold 10,000 shares of DK common stock in a prior transaction on May 18, 2026.
Delek US Holdings, Inc. director Ezra Uzi Yemin, through Yemin Investments, LP, reported open-market sales of an aggregate 200,000 shares of common stock on 2026-08-13. The shares were sold in multiple trades at weighted average prices of $65.75, $66.64, $67.74 and $68.27 per share, each representing numerous transactions within disclosed price ranges, pursuant to a Rule 10b5-1 trading plan that has now been completed. Following these transactions, Yemin reports 213,717 shares of Delek US common stock held directly.
Delek US Holdings (DK) filed a notice of proposed sale of common stock under Form 144. The filing lists 80,000 common shares to be sold through Fidelity Brokerage Services LLC, with an indicated aggregate value of $5,242,400.00 on the NYSE. It also details multiple past and future common-share acquisitions from the issuer via restricted stock vesting, categorized as compensation, across dates from December 2024 through March 2026.
J.P. Morgan Securities LLC has filed to sell 200,000 shares of DK common stock on the NYSE, with an aggregate market value of $13,396,000. The shares to be sold trace back to stock originally acquired via compensation by Ezra Uzi Yemin on multiple historical grant dates.
Delek US Holdings, Inc. has an updated Schedule 13G/A (Amendment No. 1) filed jointly by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC regarding ownership of its common stock. The Goldman Sachs reporting group indicates aggregate beneficial ownership of 1,531,064.57 shares, representing 2.5% of the class, with no sole voting or dispositive power.
The filing shows shared voting power over 1,530,754.57 shares and shared dispositive power over 1,530,796.57 shares. The reporting persons state that they are a parent holding company and broker-dealer/investment adviser, and provide customary disclosures and disclaimers about beneficial ownership, including that certain Goldman Sachs operating units may have disaggregated holdings and that beneficial ownership of some client accounts and investment entities is disclaimed.